Skip to main content / 跳转到主要内容

Public Sector Health Plan Cost Containment: International Procedure Pricing

Public sector health plans face sustained cost pressure across pharmaceutical and surgical spending. Government plans are ERISA-exempt, providing more benefit design flexibility than private-sector plans. Published international procedure pricing is available as a further reference point for plan cost evaluation.

GLP-1 Expenditure Trends and Surgical Alternatives: A Cost Comparison

GLP-1 receptor agonists (semaglutide, tirzepatide) cost $936 to $1,350 per month at US list pricing, or $11,000 to $16,000 per patient per year on an ongoing basis. Howard County (MD) Public Schools documented GLP-1 expenditure growth from $485,000 to $3.6 million in two years.

Bariatric surgery at internationally accredited facilities costs $3,900 to $7,000 as a one-time procedure (Mexico, Turkey; iFHP 2024). A 2024 JAMA Surgery cost-effectiveness analysis found that bariatric surgery produces greater long-term weight loss than GLP-1 receptor agonists and reaches cost parity with ongoing drug therapy within 6 to 8 months. The American College of Surgeons published corroborating findings. For a school district with 50 members on GLP-1s at $11,000 per year ($550,000 annually), bariatric surgery for the same cohort at international pricing represents a one-time expenditure of $195,000 to $350,000 with break-even under 8 months.

Domestic Centers of Excellence Adoption in State Plans

State government health plans are adopting domestic centres of excellence programmes. North Carolina partnered with Lantern in October 2025, covering 550,000 active members across 1,500+ non-emergency surgical procedures. Bariatric surgery became mandatory through Lantern as of January 2026.

Tennessee selected Carrum Health in April 2025 for musculoskeletal, cardiac, cancer, and substance use treatment. Maine has operated a Carrum programme since 2019; Nevada since 2023. Oregon implemented reference-based pricing at 200% of Medicare for hospital reimbursement. Financial penalties for entities exceeding cost benchmarks begin in 2026.

International published pricing extends the range of cost containment options beyond domestic COE. For plans already operating domestic COE programmes, international pricing represents an additional option on procedures that exceed what domestic bundled arrangements can offer.

Marketplace Infrastructure for Public Entities

For public entities, the marketplace requires no procurement process because no public funds are expended. Providers accredited by a body listed in the Provider Listing Agreement list procedures with published pricing. Plan members browse published procedures, compare pricing across providers and countries, and book consultations directly with the facility they select. There is no clinical intermediary, care coordination, or episode management. A benefits committee decision to include the resource in member materials is typically sufficient.

Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. Because no public funds are expended, no procurement process is triggered. The marketplace can be made available to plan members by including a reference in existing member resources.

The plan sponsor determines independently whether and how to incentivise member utilisation. Common structures include cost-sharing waivers at international facilities, travel cost coverage for the member and a companion, and shared savings arrangements. These are plan design decisions controlled by the public entity, independent of the marketplace infrastructure.

School District and Municipal Consortium Structures

School district health insurance consortiums operate small risk pools that can be vulnerable to individual catastrophic claims. SchoolCare (NH) covers approximately 65 districts and 25 other public employers. This pooled structure is a common feature of school district health financing.

Consortiums and municipal pools can make the marketplace available to all member entities through a single governance decision. Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. Nebraska's Educators Health Alliance covers nearly every school district in the state through a single governance structure. The Connecticut MEHIP, Arkansas Municipal Health Benefit Programme, and Illinois LGHP operate similarly. A single board action gives all participating entities access to the published pricing data.

Government plans established by states, political subdivisions, or their agencies are fully exempt from ERISA Titles I and IV. This exemption removes federal fiduciary standards, federal reporting requirements (Form 5500), and federal preemption of state law. In practical application, government plans have more benefit design flexibility than private-sector ERISA plans. There is no federal prohibition on including international providers in covered facility definitions. Federal employee plans already cover international care: the Blue Cross Federal Employee Programme maintains international provider networks, and the Foreign Service Benefit Plan covers all providers outside the US at in-network rates with 400+ direct billing arrangements.

Self-funded governmental plans are also largely exempt from state insurance mandates, which typically apply to "insurance" products rather than self-funded arrangements. This creates maximum flexibility for benefit design, including international provider access. ACA requirements (minimum essential coverage, non-discrimination rules, mental health parity) continue to apply. The controlling factor is the plan document, and the governing body of the public entity (school board, city council, county commission, state plan board) controls that document.

Frequently Asked Questions

A government health plan is a plan established by a state, political subdivision (county, municipality, school district), or their agencies for their employees. Under 29 USC 1003(b)(1), government plans are fully exempt from ERISA Titles I and IV. This exemption removes federal fiduciary standards, Form 5500 reporting, and ERISA preemption of state law. Government plans have broad benefit design flexibility, subject to ACA requirements and applicable state regulations. Federal employee plans, including the Foreign Service Benefit Plan, already maintain international provider arrangements.

Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. The marketplace functions as an informational resource available to plan members. A benefits committee decision or administrative action to include the reference in member materials is typically sufficient.

Government plans (established by states, political subdivisions, or their agencies) are fully exempt from ERISA Titles I and IV. This exemption provides government plans with more benefit design flexibility than private-sector ERISA plans, not less. There is no federal prohibition on covering international care. Federal employee plans already do so: the Foreign Service Benefit Plan maintains 400+ direct billing arrangements with international providers. Self-funded governmental plans have maximum benefit design authority, subject to ACA requirements and applicable state regulations.

Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. If members access the marketplace, they find published procedure pricing at internationally accredited facilities, typically well below domestic commercial equivalents.

Health insurance consortiums and municipal pools can make the marketplace available to all member entities through a single governance decision. Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. The consortium board votes to include the resource in member communications. All participating municipalities, school districts, or counties gain access. Nebraska's Educators Health Alliance and Connecticut's MEHIP are examples of structures where a single governance action covers dozens of member entities.

Adding a voluntary, additive resource occupies the strongest legal position relative to collective bargaining obligations. Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. The resource does not replace domestic coverage, does not increase member cost-sharing, and is entirely optional. In states without public sector collective bargaining (North Carolina, Virginia, Texas, Tennessee), the plan can add it unilaterally. North Carolina added the Lantern domestic COE programme without union objection; the State Employees Association of NC characterised it as 'a huge win for state employees and all taxpayers.'

Some providers or third parties offer complication cover; terms are set by them. The plan sponsor can include complication coverage as part of the benefit incentive design. Sylk Health has no clinical involvement before, during, or after treatment.

Carrum Health and Lantern are domestic centres of excellence programmes that administer surgical episodes with bundled payments, clinical coordination, and outcomes guarantees. They charge the plan per episode and require contractual arrangements. Sylk Health is marketplace infrastructure: published international pricing that members access independently. Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. The two serve different functions and are complementary. North Carolina uses Lantern for domestic mandatory bariatric referrals; international pricing data serves a separate function (voluntary member access to published pricing across broader procedure categories).

GLP-1 receptor agonists (semaglutide, tirzepatide) cost $936 to $1,350 per month ($11,000 to $16,000 per year) on an ongoing basis. Bariatric surgery at internationally accredited facilities costs $3,900 to $7,000 as a one-time procedure. According to a 2024 JAMA Surgery cost-effectiveness analysis, bariatric surgery produces greater long-term weight loss than GLP-1 receptor agonists and reaches cost parity within 6 to 8 months. Howard County (MD) Public Schools documented GLP-1 expenditure growth from $485,000 to $3.6 million over two years.

Published Pricing: International Procedures

Pricing data from internationally accredited facilities, organised by procedure category.

Sylk Health operates a marketplace platform only. It is not a healthcare provider, clinical intermediary, broker, referral service or travel service. It does not select, match, steer or recommend providers, does not rank providers by clinical quality, and does not arrange travel, accommodation, interpretation or visas. All providers listed are independent and contract directly with patients. Each provider warrants its own accreditation against the bodies listed in the Provider Listing Agreement. Sylk Health checks public registers before listing and does not assess clinical quality. Naming an accrediting body implies no endorsement by it. Every listed price is a USD range posted by the provider, who keeps it current and states what it includes and excludes. Where a United States figure is shown it is Sylk Health's own estimate from Medicare rates and published cash prices, not a provider price or a quote. Actual costs depend on the individual case. Listing order reflects commercial, geographic or algorithmic criteria applied equally to every provider. No listing is displayed in preference to another in return for commission. No sponsored placement is sold today; if one is introduced it will be labelled. Sylk Health is operated by Hydra Holding L.L.C-FZ, Meydan Free Zone, Dubai, United Arab Emirates, trade licence 2529593.01. Sylk Health processes no payment between a patient and a provider. Content on this page is for information only and is not medical, legal, actuarial or fiduciary advice. Sylk Health has no affiliation with any third-party organisation referenced on this page unless stated.